World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
103
Citations
40308
World Ranking
683
National Ranking
85

Medicine

D-Index
103
Citations
40309
World Ranking
7344
National Ranking
717

Overview

Patricia Limousin is affiliated with University College London in the United Kingdom. Their research primarily focuses on neurology and neuroscience, with a particular emphasis on neurological disorders and treatments, especially Parkinson's disease mechanisms and treatments.

Their extensive body of work spans 144 publications in medicine and 49 in neuroscience. Subfields include neurology with 138 publications, cellular and molecular neuroscience with 21, cognitive neuroscience with 13, as well as physiology and clinical psychology with 4 publications each.

Limousin's frequent publication venues include:

  • Movement Disorders Clinical Practice
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Stereotactic and Functional Neurosurgery
  • Movement Disorders
  • npj Parkinson's Disease

Key topics covered in their research are:

  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Transcranial Magnetic Stimulation Studies
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Neuroscience and Neural Engineering
  • Parkinson's Disease and Spinal Disorders

Patricia Limousin has collaborated frequently with several researchers, including:

  • Thomas Foltynie (56 joint publications)
  • Ludvic Zrinzo (44 joint publications)
  • Harith Akram (36 joint publications)
  • Jonathan Hyam (14 joint publications)
  • Nirosen Vijiaratnam (11 joint publications)

Selected recent publications include:

  • Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations, 2020, JAMA Neurology
  • Neural signatures of hyperdirect pathway activity in Parkinson's disease, 2021, Nature Communications
  • How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?, 2022, Movement Disorders
  • Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study, 2021, BMJ Open
  • Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial, 2025, The Lancet

Best Publications

  • Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

    Paul Krack;Alina Batir;Nadège Van Blercom;Stephan Chabardes

  • Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

    Patricia Limousin;Paul Krack;Pierre Pollak;Abdelhamid Benazzouz

  • Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

    P. Limousin;P. Pollak;A. Benazzouz;D. Hoffmann

  • Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders

    Alim Louis Benabid;Pierre Pollak;Dongming Gao;Dominique Hoffmann

  • Adaptive deep brain stimulation in advanced Parkinson disease

    Simon Little;Alex Pogosyan;Spencer Neal;Baltazar Zavala

  • Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance.

    Andrea A. Kühn;David Williams;Andreas Kupsch;Patricia Limousin

  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    Dilan Athauda;Kate Maclagan;Simon S Skene;Martha Bajwa-Joseph

  • Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.

    Paul Krack;Pierre Pollak;P Limousin;D Hoffmann

  • Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

    P Limousin;J D Speelman;F Gielen;M Janssens

  • Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

    Patricia Limousin;John Greene;Pierre Pollak;John Rothwell

  • Exenatide and the treatment of patients with Parkinson’s disease

    Iciar Aviles-Olmos;John Dickson;Zinovia Kefalopoulou;Atbin Djamshidian

  • Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients

    C. Ardouin;B. Pillon;E. Peiffer;P. Bejjani

  • α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

    Aoife P. Kiely;Yasmine T. Asi;Eleanna Kara;Patricia Limousin;Patricia Limousin

  • Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease

    Vladimir Litvak;Vladimir Litvak;Ashwani Jha;Ashwani Jha;Alexandre Eusebio;Robert Oostenveld

  • Long-Term Electrical Inhibition of Deep Brain Targets in Movement Disorders

    A L Benabid;A Benazzouz;D Hoffmann;P Limousin

  • Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease

    L.A. Robak;L.A. Robak;I.E. Jansen;I.E. Jansen;J van Rooij;A.G. Uitterlinden

  • Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

    Suzanne Lesage;Valérie Drouet;Elisa Majounie;Vincent Deramecourt

  • Long-term outcomes of deep brain stimulation in Parkinson disease

    Patricia Limousin;Tom Foltynie

  • Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

    A. Beilina;I. N. Rudenko;A. Kaganovich;L. Civiero

  • Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review.

    Ludvic Zrinzo;Thomas Foltynie;Patricia Limousin;Marwan I. Hariz;Marwan I. Hariz

  • Opposite motor effects of pallidal stimulation in Parkinson's disease.

    Paul Krack;Pierre Pollak;P Limousin;D Hoffmann

Frequent Co-Authors

Marwan Hariz
Marwan Hariz Umeå University
Thomas Foltynie
Thomas Foltynie University College London
Ludvic Zrinzo
Ludvic Zrinzo University College London
Peter Brown
Peter Brown University of Oxford
Marjan Jahanshahi
Marjan Jahanshahi University College London
Kailash P. Bhatia
Kailash P. Bhatia University College London
Andrew J. Lees
Andrew J. Lees University College London
Huiling Tan
Huiling Tan University of Oxford
Alek Pogosyan
Alek Pogosyan University of Oxford
Alexander L. Green
Alexander L. Green University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in neuroscience, you may also want to explore related online degrees and diverse career pathways in mental health and behavioral sciences. Many students opt for online programs such as marriage and family masters programs, which offer a direct route to working with families and couples in clinical settings.

A masters in psychology online can open doors to a wide variety of roles, from research to counseling. Cost is an important factor—prospective students should compare the psychology degree cost across accredited programs to find an option that fits their budget.

Additionally, those interested in social work can consider msw programs with high acceptance rate. These programs may offer a more accessible pathway for career entry while still providing valuable training for a range of clinical and community roles.

Exploring these options can help you find the best fit for your professional goals in neuroscience and related fields.

Best Scientists Citing Patricia Limousin

Trending Scientists

Recently Published Articles